Gastrointestinal Cancer
From the Journals
Low-dose olanzapine improves appetite in chemotherapy patients
About half of patients who took olanzapine consumed more than 75% of recommended daily calories.
From the Journals
Gene variants plus H. pylori increase risk of gastric cancer
The new findings imply that the hereditary contribution to the risk of gastric cancer is more important than previously believed.
Latest News
Possible C. difficile–colon cancer connection: Study
Mouse study makes a connection between C. diff. and colon cancer.
From the Journals
AI-assisted colonoscopy doesn’t always improve adenoma detection: Study
“I’m not convinced that we have a good answer yet for where to go from here, but we need to keep working with our AI colleagues to figure out how...
Conference Coverage
Plant-based diet linked to better outcomes in prostate cancer
Men who consumed more fruits and vegetables had slower cancer progression and lower risk of recurrence.
Commentary
Can particles in dairy and beef cause cancer and MS?
Researchers found single-stranded DNA rings that originated in viruses, which they named bovine meat and milk factors, in the intestines of...
News
Review explores the boundaries of endoscopic resection for esophageal adenocarcinoma
Technical advances are expanding the population of patients who are candidates for endoscopic resection of esophageal adenocarcinoma.
From the Journals
Defensiveness may drive refusal for colon cancer screening
An Irish study pinpoints excuses for putting off screening and discounting one’s risk of colorectal cancer.
From the Journals
Does CRC risk in IBD extend to close family members?
Extra screening for CRC may not be needed for children, siblings, or parents of those with IBD, new study findings suggest.
From the Journals
Colorectal cancer incidence doubled in younger adults
Diagnoses in people younger than 55 years doubled from 1995 to 2019.
From the Journals
Pancreatic cancer incidence increases among young women in U.S.
Additional studies are needed to investigate contributing factors, particularly race and tumor characteristics.